Neurent Medical

Experience the Difference

United States · $110.0M raised

Employees
11–50
Business Model
B2B
Total Funding
$110.0M
Last Round
$74.0M Series CFeb 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Neurent Medical is a medical device company developing the NEUROMARK System, a minimally invasive radiofrequency ablation device for treating chronic rhinitis (CR) by targeting overactive posterior nasal nerves. The NEUROMARK System uses low-power energy to disrupt these nerves, providing durable relief from CR symptoms including runny nose, congestion, and postnasal drip, with 91% of clinical trial participants achieving clinically meaningful improvement at one year. The company's mission is to offer ENT providers a precise, safe, and clinically proven treatment that addresses the root cause of CR rather than just managing symptoms.

Summary

Neurent Medical is a Healthcare company based in United States. It has raised $110.0M in total across 3 rounds, most recently a $74.0M Series C round in Feb 2026. Investors include Fountain Healthcare Partners, MVM Partners and EQT AB.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CFeb 2026
$74.0M

Sign up to see all 3 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurent Medical on Indexed.vc
<a href="https://indexed.vc/companies/neurent-medical"><img src="https://indexed.vc/api/badge/company/neurent-medical" alt="Neurent Medical on Indexed.vc" width="260" height="76" /></a>